.svg)
Pradaxa 110 Mg
Price range: $62.40 through $158.40
Pradaxa 110 mg is an oral anticoagulant used to prevent and treat blood clots in various conditions, including non-valvular atrial fibrillation (AFib) and deep vein thrombosis (DVT). It contains Dabigatran Etexilate, a direct thrombin inhibitor that effectively prevents the formation of blood clots by inhibiting thrombin, an enzyme crucial for blood clotting.
Description
Pradaxa 110 Mg
Pradaxa 110 Mg is an oral anticoagulant containing dabigatran etexilate, used to prevent and treat blood clots. It is commonly prescribed for atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). This mid-strength dose is often used in patients requiring effective anticoagulation with a balanced bleeding risk profile.
Mechanism of Action
Direct Thrombin Inhibitor
Pradaxa works by directly inhibiting thrombin, an enzyme essential for clot formation.
Clot Prevention
This action prevents fibrin clot formation, reducing the risk of stroke and thromboembolic events.
Medical Uses
Pradaxa 110 Mg is used for:
- Stroke prevention in atrial fibrillation
- Treatment and prevention of DVT
- Treatment and prevention of pulmonary embolism
Dosage and Administration
It is taken orally, usually twice daily, as prescribed by a healthcare provider. Capsules should be swallowed whole with water and should not be crushed or chewed. Dose selection depends on patient condition, kidney function, and bleeding risk.
Lower doses such as Dabigatran Etexilate Capsules 75 Mg are used for dose adjustment, while higher strengths like Dabigatran Etexilate Capsules 150 Mg are prescribed for standard anticoagulation based on patient condition.
Clinical Effectiveness
Clinical studies show that Pradaxa effectively reduces the risk of stroke and systemic embolism, offering predictable anticoagulation without routine INR monitoring in most patients.
Safety and Side Effects
Common Side Effects
- Indigestion
- Stomach discomfort
- Mild bleeding
Serious Risks
- Severe bleeding
- Gastrointestinal bleeding
Medical supervision is important during treatment.
Contraindications and Precautions
Pradaxa should be used with caution in:
- Patients with kidney impairment
- Individuals with bleeding disorders
- Patients undergoing surgery
Proper evaluation is necessary before use.
Drug Interactions
Pradaxa may interact with other anticoagulants, antiplatelet drugs, and medications affecting bleeding risk. Patients should inform their healthcare provider about all medicines they are taking.
FAQs
Pradaxa 110 Mg is used to prevent stroke in patients with atrial fibrillation and to treat or prevent deep vein thrombosis and pulmonary embolism. It reduces the risk of blood clot formation and helps maintain proper blood circulation, lowering the chances of serious cardiovascular complications.
Pradaxa works by inhibiting thrombin, a key enzyme involved in blood clot formation. By blocking thrombin, it prevents fibrin clot development. This mechanism helps maintain smooth blood flow and significantly reduces the risk of stroke and other clot-related complications.
It should be taken orally, usually twice daily, as prescribed by a doctor. Capsules must be swallowed whole with water and not crushed or chewed. Consistent use at the same time each day ensures effective anticoagulation and reduces the risk of clot formation.
It is generally safe when used under medical supervision, but it carries a risk of bleeding. Patients should follow dosage instructions carefully and report any unusual bleeding. Regular monitoring helps ensure safe and effective use for preventing and treating blood clots.
Common side effects include indigestion, stomach discomfort, and mild bleeding such as bruising or nosebleeds. These are usually manageable. Serious side effects include severe bleeding, which requires immediate medical attention if symptoms become severe or persistent during treatment.
RELATED PRODUCTS
Dabigatran Etexilate Capsules 150 Mg
